Guo Y - Search Results

1

Development of new versions of anti-human CD34 monoclonal antibodies with potentially reduced immunogenicity.

Qian W, Wang L, Li B, Wang H, Hou S, Hong X, Zhang D, Guo Y. Qian W, et al. Among authors: guo y. Biochem Biophys Res Commun. 2008 Mar 7;367(2):497-502. doi: 10.1016/j.bbrc.2007.12.184. Epub 2008 Jan 9. Biochem Biophys Res Commun. 2008. PMID: 18190781

2

Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions.

Li B, Wang H, Dai J, Ji J, Qian W, Zhang D, Hou S, Guo Y. Li B, et al. Among authors: guo y. Immunology. 2005 Dec;116(4):487-98. doi: 10.1111/j.1365-2567.2005.02247.x. Immunology. 2005. PMID: 16313362 Free PMC article.

3

Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody.

Li B, Wang H, Zhang D, Qian W, Hou S, Shi S, Zhao L, Kou G, Cao Z, Dai J, Guo Y. Li B, et al. Among authors: guo y. Biochem Biophys Res Commun. 2007 Jun 15;357(4):951-6. doi: 10.1016/j.bbrc.2007.04.039. Epub 2007 Apr 17. Biochem Biophys Res Commun. 2007. PMID: 17451647

4

Functional and stable expression of recombinant human FOXP3 in bacterial cells and development of antigen-specific monoclonal antibodies.

Hu S, Dai J, Wei H, Fan K, Wang H, Zhang D, Qian W, Li B, Wang H, Zhu T, Zhang Y, Guo Y. Hu S, et al. Among authors: guo y. J Biochem. 2007 Oct;142(4):471-80. doi: 10.1093/jb/mvm160. Epub 2007 Aug 30. J Biochem. 2007. PMID: 17761693

5

Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity.

Li B, Shi S, Qian W, Zhao L, Zhang D, Hou S, Zheng L, Dai J, Zhao J, Wang H, Guo Y. Li B, et al. Among authors: guo y. Cancer Res. 2008 Apr 1;68(7):2400-8. doi: 10.1158/0008-5472.CAN-07-6663. Cancer Res. 2008. PMID: 18381448

6

Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling.

Hou S, Li B, Wang L, Qian W, Zhang D, Hong X, Wang H, Guo Y. Hou S, et al. Among authors: guo y. J Biochem. 2008 Jul;144(1):115-20. doi: 10.1093/jb/mvn052. Epub 2008 Apr 19. J Biochem. 2008. PMID: 18424812

7

PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity.

Gao J, Kou G, Wang H, Chen H, Li B, Lu Y, Zhang D, Wang S, Hou S, Qian W, Dai J, Zhao J, Zhong Y, Guo Y. Gao J, et al. Among authors: guo y. Breast Cancer Res Treat. 2009 May;115(1):29-41. doi: 10.1007/s10549-008-0043-0. Epub 2008 May 15. Breast Cancer Res Treat. 2009. PMID: 18481173

8

Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection.

Kou G, Wang S, Cheng C, Gao J, Li B, Wang H, Qian W, Hou S, Zhang D, Dai J, Gu H, Guo Y. Kou G, et al. Among authors: guo y. Biochem Biophys Res Commun. 2008 Sep 19;374(2):192-7. doi: 10.1016/j.bbrc.2008.06.126. Epub 2008 Jul 11. Biochem Biophys Res Commun. 2008. PMID: 18621023

9

Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab.

Zheng L, Li B, Qian W, Zhao L, Cao Z, Shi S, Gao J, Zhang D, Hou S, Dai J, Wang H, Guo Y. Zheng L, et al. Among authors: guo y. Biochem Biophys Res Commun. 2008 Oct 31;375(4):619-22. doi: 10.1016/j.bbrc.2008.08.055. Epub 2008 Aug 24. Biochem Biophys Res Commun. 2008. PMID: 18725193

10

Development and characterization of a fully functional small anti-HER2 antibody.

Gao J, Li B, Li H, Zhang X, Zhang D, Zhao L, Wang C, Fang C, Qian W, Hou S, Kou G, Wei H, Shi S, Wang H, Guo Y. Gao J, et al. Among authors: guo y. BMB Rep. 2009 Oct 31;42(10):636-41. doi: 10.5483/bmbrep.2009.42.10.636. BMB Rep. 2009. PMID: 19874707 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44,387 results

Search Page

Filters